Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 491

1.

Cognitive performance and the course of depressive symptoms over 7 years of follow-up: the SMART-MR study.

Kooistra M, Zuithoff NP, Grool AM, Zinsmeester M, Biessels GJ, van der Graaf Y, Geerlings MI.

Psychol Med. 2014 Dec 11:1-10. [Epub ahead of print]

PMID:
25499398
[PubMed - as supplied by publisher]
2.

The interdependence between cardiovascular calcifications in different arterial beds and vascular risk factors in patients at high cardiovascular risk.

Takx RA, Zanen P, Leiner T, van der Graaf Y, de Jong PA; SMART study group.

Atherosclerosis. 2014 Nov 29;238(1):140-146. doi: 10.1016/j.atherosclerosis.2014.11.024. [Epub ahead of print]

PMID:
25485737
[PubMed - as supplied by publisher]
3.

Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women.

van Kruijsdijk RC, Visseren FL, Ridker PM, Dorresteijn JA, Buring JE, van der Graaf Y, Cook NR.

Heart. 2014 Dec 4. pii: heartjnl-2014-306342. doi: 10.1136/heartjnl-2014-306342. [Epub ahead of print]

PMID:
25475110
[PubMed - as supplied by publisher]
4.

Paternal or maternal history of cardiovascular disease and the risk of cardiovascular disease in offspring. A systematic review and meta-analysis.

Weijmans M, van der Graaf Y, Reitsma JB, Visseren FL.

Int J Cardiol. 2015 Jan 20;179:409-16. doi: 10.1016/j.ijcard.2014.11.017. Epub 2014 Nov 5.

PMID:
25464496
[PubMed - in process]
5.

Vertebral fractures on routine chest computed tomography: relation with arterial calcifications and future cardiovascular events.

Buckens CF, de Jong PA, Verkooijen HM, Verhaar HJ, Mali WP, van der Graaf Y; PROVIDI study group.

Int J Cardiovasc Imaging. 2014 Dec 2. [Epub ahead of print]

PMID:
25451815
[PubMed - as supplied by publisher]
6.

The relation between resting heart rate and cancer incidence, cancer mortality and all-cause mortality in patients with manifest vascular disease.

van Kruijsdijk RC, van der Graaf Y, Bemelmans RH, Nathoe HM, Peeters PH, Visseren FL; SMART study group.

Cancer Epidemiol. 2014 Dec;38(6):715-21. doi: 10.1016/j.canep.2014.09.004. Epub 2014 Oct 17.

PMID:
25448083
[PubMed - in process]
7.

Osteoporosis markers on low-dose lung cancer screening chest computed tomography scans predict all-cause mortality.

Buckens CF, van der Graaf Y, Verkooijen HM, Mali WP, Isgum I, Mol CP, Verhaar HJ, Vliegenthart R, Oudkerk M, van Aalst CM, de Koning HJ, de Jong PA.

Eur Radiol. 2015 Jan;25(1):132-9. doi: 10.1007/s00330-014-3361-0. Epub 2014 Sep 25.

PMID:
25323601
[PubMed - in process]
8.

Predicting the Effects of Blood Pressure-Lowering Treatment on Major Cardiovascular Events for Individual Patients With Type 2 Diabetes Mellitus: Results From Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation.

van der Leeuw J, Visseren FL, Woodward M, Zoungas S, Kengne AP, van der Graaf Y, Glasziou P, Hamet P, MacMahon S, Poulter N, Grobbee DE, Chalmers J.

Hypertension. 2015 Jan;65(1):115-21. doi: 10.1161/HYPERTENSIONAHA.114.04421. Epub 2014 Oct 13.

PMID:
25312436
[PubMed - in process]
9.

The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus.

van der Leeuw J, van Dieren S, Beulens JW, Boeing H, Spijkerman AM, van der Graaf Y, van der A DL, Nöthlings U, Visseren FL, Rutten GE, Moons KG, van der Schouw YT, Peelen LM.

Heart. 2014 Sep 25. pii: heartjnl-2014-306068. doi: 10.1136/heartjnl-2014-306068. [Epub ahead of print]

PMID:
25256148
[PubMed - as supplied by publisher]
10.

Quality and reporting of publications by Indonesian researchers: a literature survey.

Widyahening IS, Wangge G, Saldi SR, Lestari BW, Apriani L, Sastroasmoro S, Glasziou P, van der Graaf Y, van der Heijden GJ.

J Evid Based Med. 2014 Aug 8. doi: 10.1111/jebm.12112. [Epub ahead of print]

PMID:
25156942
[PubMed - as supplied by publisher]
11.

Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population.

Selvarajah S, Kaur G, Haniff J, Cheong KC, Hiong TG, van der Graaf Y, Bots ML.

Int J Cardiol. 2014 Sep;176(1):211-8. doi: 10.1016/j.ijcard.2014.07.066. Epub 2014 Jul 15.

PMID:
25070380
[PubMed - in process]
Free Article
12.

Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease.

van de Woestijne AP, van der Graaf Y, de Bakker PI, Asselbergs FW, Spiering W, Visseren FL; SMART Study Group.

PLoS One. 2014 Jun 30;9(6):e101082. doi: 10.1371/journal.pone.0101082. eCollection 2014.

PMID:
24979386
[PubMed - in process]
Free PMC Article
13.

Global brain atrophy but not hippocampal atrophy is related to type 2 diabetes.

Wisse LE, de Bresser J, Geerlings MI, Reijmer YD, Portegies ML, Brundel M, Kappelle LJ, van der Graaf Y, Biessels GJ; Utrecht Diabetic Encephalopathy Study Group; SMART-MR Study Group.

J Neurol Sci. 2014 Sep 15;344(1-2):32-6. doi: 10.1016/j.jns.2014.06.008. Epub 2014 Jun 14.

PMID:
24958596
[PubMed - in process]
14.

Age and sex based reference values for incidental coronary artery and thoracic aorta calcifications on routine clinical chest CT: a powerful tool to appreciate available imaging findings.

Jairam PM, de Jong PA, Mali WP, Gondrie MJ, Jacobs PC, van der Graaf Y; PROVIDI Study-Group.

Atherosclerosis. 2014 Aug;235(2):546-53. doi: 10.1016/j.atherosclerosis.2014.05.949. Epub 2014 Jun 9.

PMID:
24956527
[PubMed - in process]
15.

Metabolic syndrome, prediabetes, and brain abnormalities on mri in patients with manifest arterial disease: the SMART-MR study.

Tiehuis AM, van der Graaf Y, Mali WP, Vincken K, Muller M, Geerlings MI; SMART Study Group.

Diabetes Care. 2014 Sep;37(9):2515-21. doi: 10.2337/dc14-0154. Epub 2014 Jun 19.

PMID:
24947788
[PubMed - in process]
16.

Influence of APOE-2 genotype on the relation between adiposity and plasma lipid levels in patients with vascular disease.

Koopal C, van der Graaf Y, Asselbergs FW, Westerink J, Visseren FL.

Int J Obes (Lond). 2014 Jun 20. doi: 10.1038/ijo.2014.105. [Epub ahead of print]

PMID:
24946908
[PubMed - as supplied by publisher]
17.

Incidental imaging findings from routine chest CT used to identify subjects at high risk of future cardiovascular events.

Jairam PM, Gondrie MJ, Grobbee DE, Mali WP, Jacobs PC, van der Graaf Y; PROVIDI Study Group.

Radiology. 2014 Sep;272(3):700-8. doi: 10.1148/radiol.14132211. Epub 2014 May 27.

PMID:
24865309
[PubMed - indexed for MEDLINE]
18.

The separate and combined effects of adiposity and cardiometabolic dysfunction on the risk of recurrent cardiovascular events and mortality in patients with manifest vascular disease.

van der Leeuw J, van der Graaf Y, Nathoe HM, de Borst GJ, Kappelle LJ, Visseren FL; SMART study group.

Heart. 2014 Sep 15;100(18):1421-9. doi: 10.1136/heartjnl-2014-305490. Epub 2014 May 9.

PMID:
24817441
[PubMed - indexed for MEDLINE]
19.

Awareness, agreement, adoption and adherence to type 2 diabetes mellitus guidelines: a survey of Indonesian primary care physicians.

Widyahening IS, van der Graaf Y, Soewondo P, Glasziou P, van der Heijden GJ.

BMC Fam Pract. 2014 Apr 23;15:72. doi: 10.1186/1471-2296-15-72.

PMID:
24755412
[PubMed - in process]
Free PMC Article
20.

Parental history and the risk of subsequent vascular events in patients with clinically manifest vascular disease: the effects of sex of the parent and vascular disease location.

Weijmans M, van der Graaf Y, de Borst GJ, Nathoe HM, Algra A, Visseren FL; SMART study group.

Atherosclerosis. 2014 May;234(1):129-35. doi: 10.1016/j.atherosclerosis.2014.02.018. Epub 2014 Mar 3.

PMID:
24650753
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk